One common complaint I hear from biotech entrepreneurs is that negotiating a license agreement with a university can be a nightmare. There are universities—some of them within the very top echelons of academia—that are infamous for having technology transfer people who are described as very difficult to work with.
It’s not that surprising that these two factions of the life sciences ecosystem—the intellectual property generators in academia and intellectual property seekers in companies—clash over their perceived value of this key asset.
To read the full, original article click on this link: A One-Size-Fits-All License Agreement: The Holy Grail of Tech Transfer? | Xconomy
Author: Sylvia Pagán Westphal
